PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 29(Supplement_2): 111-114
2009
© 2009 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehrotra, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehrotra, R.

Part 3: Clinical Experiences

LONG-TERM OUTCOMES IN AUTOMATED PERITONEAL DIALYSIS: SIMILAR OR BETTER THAN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS?

Rajnish Mehrotra

Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor–UCLA, Torrance, and David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.

Correspondence to: R. Mehrotra, 1124 W. Carson Street, Torrance, California 90502 U.S.A. rmehrotra{at}labiomed.org

In many parts of the world, a progressively larger proportion of chronic peritoneal dialysis (PD) patients are being treated with automated PD (APD). Increasingly, the decision to use APD is being dictated by patient and physician preference rather than being based on medical considerations. It is important to determine if the PD modality has any effect on long-term patient outcomes. Studies examining the effects of APD on residual renal function have been inconsistent, and the effect of cycler use on native renal clearances, if any, is small and probably not clinically significant. The preponderance of the evidence suggests that peritonitis rates are somewhat lower in APD patients than in patients treated with continuous ambulatory PD (CAPD). Two of three recent studies indicated that the risk for transfer to maintenance hemodialysis may be lower in APD patients, particularly in the early period after starting chronic PD. However, the risk for death in patients treated with CAPD and APD appears to be similar in most of the studies that have looked at that question. In summary, the long-term outcomes of CAPD and APD appear to be similar, and patient and physician preference are likely to increase the utilization of APD in many parts of the world.

KEY WORDS: CAPD; automated peritoneal dialysis; end-stage renal disease; residual renal function; peritonitis; mortality.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
D. W. Johnson, C. M. Hawley, S. P. McDonald, F. G. Brown, J. B. Rosman, K. J. Wiggins, K. M. Bannister, and S. V. Badve
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis
Nephrol. Dial. Transplant., February 1, 2010; (2010): gfp780v3 - gfp780.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2009 by Multimed Inc.